Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma

Clinical trial NCT05535673 · UNKNOWN

Trial details

NCT number: NCT05535673
Sponsor: Zhengzhou University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL

Start date: 2022-09-02
Primary completion: 2025-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.